Aeterna Zentaris, Orient Europharma deal

Aeterna granted Orient’s Cyntec Co. Ltd. affiliate exclusive rights to develop and commercialize Zoptrex zoptarelin doxorubicin for endometrial cancer in Taiwan, the Philippines, Singapore, Malaysia,...